Geode Capital Management’s Clearside Biomedical CLSD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-52,741
| Closed | -$209K | – | 4493 |
|
|
2025
Q3 | $209K | Buy |
52,741
+49
| +0.1% | +$334 | ﹤0.01% | 3906 |
|
|
2025
Q2 | $632K | Sell |
52,692
-124
| -0.2% | -$1.54K | ﹤0.01% | 3477 |
|
|
2025
Q1 | $727K | Buy |
52,816
+1,879
| +4% | +$27K | ﹤0.01% | 3411 |
|
|
2024
Q4 | $726K | Buy |
50,937
+2,178
| +4% | +$35.8K | ﹤0.01% | 3482 |
|
|
2024
Q3 | $929K | Buy |
48,759
+3,939
| +9% | +$67.2K | ﹤0.01% | 3379 |
|
|
2024
Q2 | $874K | Buy |
44,820
+2,006
| +5% | +$38.8K | ﹤0.01% | 3356 |
|
|
2024
Q1 | $983K | Buy |
42,814
+10,101
| +31% | +$218K | ﹤0.01% | 3363 |
|
|
2023
Q4 | $574K | Hold |
32,713
| – | – | ﹤0.01% | 3556 |
|
|
2023
Q3 | $427K | Sell |
32,713
-567
| -2% | -$8.59K | ﹤0.01% | 3663 |
|
|
2023
Q2 | $559K | Sell |
33,280
-2,060
| -6% | -$35.5K | ﹤0.01% | 3598 |
|
|
2023
Q1 | $551K | Hold |
35,340
| – | – | ﹤0.01% | 3606 |
|
|
2022
Q4 | $593K | Buy |
35,340
+320
| +0.9% | +$5.76K | ﹤0.01% | 3585 |
|
|
2022
Q3 | $593K | Buy |
35,020
+87
| +0.2% | +$1.91K | ﹤0.01% | 3636 |
|
|
2022
Q2 | $770K | Buy |
34,933
+2,271
| +7% | +$55.1K | ﹤0.01% | 3537 |
|
|
2022
Q1 | $1.12M | Buy |
32,662
+219
| +0.7% | +$6.55K | ﹤0.01% | 3566 |
|
|
2021
Q4 | $1.34M | Hold |
32,443
| – | – | ﹤0.01% | 3567 |
|
|
2021
Q3 | $2.92M | Buy |
32,443
+4,207
| +15% | +$371K | ﹤0.01% | 3195 |
|
|
2021
Q2 | $2.06M | Buy |
28,236
+3,921
| +16% | +$182K | ﹤0.01% | 3261 |
|
|
2021
Q1 | $900K | Buy |
24,315
+2,569
| +12% | +$129K | ﹤0.01% | 3598 |
|
|
2020
Q4 | $893K | Hold |
21,746
| – | – | ﹤0.01% | 3398 |
|
|
2020
Q3 | $502K | Hold |
21,746
| – | – | ﹤0.01% | 3429 |
|
|
2020
Q2 | $613K | Hold |
21,746
| – | – | ﹤0.01% | 3300 |
|
|
2020
Q1 | $554K | Buy |
21,746
+3,344
| +18% | +$124K | ﹤0.01% | 3247 |
|
|
2019
Q4 | $800K | Buy |
18,402
+2,057
| +13% | +$43.2K | ﹤0.01% | 3353 |
|
|
2019
Q3 | $154K | Sell |
16,345
-54
| -0.3% | -$774 | ﹤0.01% | 3854 |
|
|
2019
Q2 | $239K | Sell |
16,399
-4,907
| -23% | -$87.5K | ﹤0.01% | 3740 |
|
|
2019
Q1 | $441K | Buy |
21,306
+1,072
| +5% | +$21.3K | ﹤0.01% | 3480 |
|
|
2018
Q4 | $324K | Buy |
20,234
+945
| +5% | +$44.3K | ﹤0.01% | 3526 |
|
|
2018
Q3 | $1.78M | Buy |
19,289
+953
| +5% | +$113K | ﹤0.01% | 2951 |
|
|
2018
Q2 | $2.94M | Buy |
18,336
+2,147
| +13% | +$362K | ﹤0.01% | 2624 |
|
|
2018
Q1 | $2.6M | Buy |
16,189
+7,533
| +87% | +$918K | ﹤0.01% | 2623 |
|
|
2017
Q4 | $908K | Buy |
8,656
+250
| +3% | +$26.8K | ﹤0.01% | 3139 |
|
|
2017
Q3 | $1.1M | Buy |
8,406
+200
| +2% | +$24.4K | ﹤0.01% | 3080 |
|
|
2017
Q2 | $1.12M | Buy |
8,206
+1,784
| +28% | +$214K | ﹤0.01% | 3056 |
|
|
2017
Q1 | $764K | Buy |
6,422
+373
| +6% | +$44K | ﹤0.01% | 3140 |
|
|
2016
Q4 | $811K | Buy |
6,049
+3,244
| +116% | +$814K | ﹤0.01% | 3092 |
|
|
2016
Q3 | $730K | Buy |
+2,805
| New | +$344K | ﹤0.01% | 3097 |
|
Other funds holding CLSD
Geode Capital Management's CLSD Position: Q4 2025 in Review
Geode Capital Management sold out of Clearside Biomedical (CLSD) in Q4 2025, closing a stake of 52,741 shares — an estimated $209K sold.
Geode Capital Management first reported a position in CLSD in Q3 2016 and held it in 37 quarters. The position peaked at $2.94M in Q2 2018. 1 fund tracked by Wall St. Rank holds CLSD as of Q4 2025.
- Geode Capital Management reported no remaining Clearside Biomedical position as of Q4 2025 after selling out during the quarter.
- Geode Capital Management sold 52,741 Clearside Biomedical shares in Q4 2025, an estimated $209K.
- Geode Capital Management first reported a position in Clearside Biomedical in Q3 2016 and held it in 37 quarters.
- Geode Capital Management's Clearside Biomedical position peaked at $2.94M in Q2 2018.
- 1 fund tracked by Wall St. Rank held Clearside Biomedical as of Q4 2025.
Based on Geode Capital Management's 13F filing for Q4 2025, filed 9 Feb 2026.